论文部分内容阅读
目的探究雾化吸入布地奈德联合阿奇霉素治疗小儿肺炎支原体肺炎的临床疗效。方法 160例肺炎支原体肺炎患儿,随机分成对照组和观察组,各80例。对照组患儿采用阿奇霉素治疗,观察组患儿雾化吸入布地奈德联合阿奇霉素治疗。对比分析两组患儿总有效率、住院时间以及退热时间。结果观察组患儿治疗总有效率明显高于对照组,差异具有统计学意义(P<0.05)。观察组患儿住院时间以及退热时间明显少于对照组,差异具有统计学意义(P<0.05)。结论雾化吸入布地奈德联合阿奇霉素治疗小儿肺炎支原体肺炎临床效果显著,不仅能够有效地提高治疗有效率,还能够极大的缩短住院的时间以及退热的时间,值得临床推广使用。
Objective To investigate the clinical efficacy of inhalation of budesonide combined with azithromycin in the treatment of children with Mycoplasma pneumoniae pneumonia. Methods 160 cases of Mycoplasma pneumoniae pneumonia were randomly divided into control group and observation group, 80 cases each. The control group of children treated with azithromycin, the observation group of children inhaled budesonide combined azithromycin treatment. The total effective rate, hospitalization time and antipyretic time of two groups were compared and analyzed. Results The total effective rate of observation group was significantly higher than that of control group, the difference was statistically significant (P <0.05). The hospitalization time and the antipyretic time in the observation group were significantly less than those in the control group, the difference was statistically significant (P <0.05). Conclusion Inhaled budesonide combined azithromycin treatment of children with Mycoplasma pneumoniae pneumonia clinical effect is significant, not only can effectively improve the treatment efficiency, but also can greatly reduce the length of hospital stay and fever, it is worth to promote the use of the clinic.